1. Memories of and reflection on play. Issue 1 (2nd January 2017) Authors: Conlon, Kelly Journal: International journal of play Issue: Volume 6:Issue 1(2017) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deferitazole, a new orally active iron chelator. Issue 11 (17th February 2015) Authors: Hider, Robert C.; Kong, Xiaole; Abbate, Vincenzo; Harland, Rachel; Conlon, Kelly; Luker, Tim Journal: Dalton transactions Issue: Volume 44:Issue 11(2015) Page Start: 5197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-57. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA. (12th November 2021) Authors: Palmer, Greg; Keir, Stephen T; Ashley, David M; Davies, Rhian; Williams, Ben; Rees, Zoe; Laemont, Keith; Belloni, Rafaela; Damment, Stephen J P; Conlon, Kelly Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-36. INITIATION OF A PHASE 1 DOSE-ESCALATING STUDY OF WEEKLY DIRECT-TO-BRAIN ADMINISTRATION OF SOLUBILISED FORMULATION OF PANOBINOSTAT (MTX110) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (MAGIC-G1 STUDY). (14th November 2022) Authors: Desjardins, Annick; Conlon, Kelly; Gunning, Hannah; Davies, Rhian; Komisarow, Jordan; Cavaliere, Robert; Zamoryakhin, Dmitry Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TMOD-27. EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA. (9th November 2020) Authors: Ashley, David; Keir, Stephen T; Roskoski, Martin A; Davies, Rhian; Williams, Ben; Damment, Stephen J P; Conlon, Kelly Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma. Issue 24 (15th December 2020) Authors: Porter, John; Ding, Yao; Hale, Sarah J.M.; Perrins, Richard D.; Robinson, Angela; Mazanetz, Michael P.; Wu, Yubo; Ma, Yinping; Conlon, Kelly; Coulter, Tom Journal: Bioorganic & medicinal chemistry letters Issue: Volume 30:Issue 24(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Deferitazole, a new orally active iron chelator1. Issue 11 (21st March 2015) Authors: Hider, Robert C.; Kong, Xiaole; Abbate, Vincenzo; Harland, Rachel; Conlon, Kelly; Luker, Tim Journal: Dalton transactions Issue: Volume 44:Issue 11(2015) Page Start: 5197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗